Business Context and Reporting Period
Company: Healthcare Triangle, Inc. (HCTI)
Filing Type: Form 8-K (Current Report)
Date of Report: July 2, 2025
Reporting Period: Event date July 2, 2025; Press release issued July 7, 2025.
Context: The Company is an emerging growth company listed on The Nasdaq Capital Market. This filing addresses a decision by the Nasdaq Hearings Panel regarding the Company's continued listing status following deficiencies in bid price and shareholder equity rules.
Key Financial Metrics
This filing is a current report regarding regulatory compliance and listing status. It does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The filing text does not provide a clear value for any financial metrics.
Material Changes and Listing Status
On July 2, 2025, the Nasdaq Hearings Panel granted Healthcare Triangle, Inc. a request for continued listing on The Nasdaq Capital Market. The Panel made the following determinations:
- Found the Company in compliance with Nasdaq's shareholders' equity rule.
- Granted an exception to cure a bid price deficiency.
- Declined to delist the Company's securities based on previously cited public interest concerns.
Conditions for Continued Listing:
- Reverse Stock Split: Must be effected on or before August 8, 2025, at a ratio sufficient to achieve and maintain long-term compliance with the bid price rule.
- Bid Price Compliance: Must demonstrate compliance by maintaining a closing bid price of at least $1.00 per share for a minimum of 20 consecutive trading days on or before September 5, 2025.
- Monitoring: A discretionary panel monitor will be imposed for a one-year period upon the Company regaining compliance with the bid price rule.
Guidance, Outlook, and Risks
Outlook: The Company intends to comply with the Panel's conditions to maintain its listing. A press release detailing the decision was issued on July 7, 2025.
Risks and Contingencies:
- Delisting Risk: Failure to meet the August 8, 2025, reverse stock split deadline or the September 5, 2025, bid price maintenance requirement could result in delisting.
- Forward-Looking Statements: The filing includes standard disclaimers that forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from expectations. Specific risk factors are referenced in the Company's Annual Report on Form 10-K filed on March 31, 2025.
Investor Verification Checklist
- Verify the announcement and terms of the reverse stock split by August 8, 2025.
- Monitor the daily closing bid price to ensure it remains above $1.00 for 20 consecutive trading days prior to September 5, 2025.
- Review the Company's Form 10-K (filed March 31, 2025) for detailed risk factors and financial health context not included in this 8-K.
- Confirm the appointment and reporting requirements of the discretionary panel monitor once compliance is regained.